%PDF-1.4
%
32 0 obj
<>
endobj
29 0 obj
<>
endobj
527 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-02T17:14:16Z
2024-03-29T01:56:21-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-29T01:56:21-07:00
application/pdf
Heather
2001-162.jan
uuid:c1f02f35-1dd1-11b2-0a00-a308278d5b00
uuid:c1f02f38-1dd1-11b2-0a00-1e0000000000
endstream
endobj
18 0 obj
<>
endobj
19 0 obj
<>
endobj
33 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
539 0 obj
[544 0 R]
endobj
540 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 cs 0 0 0 0 scn
/GS1 gs
465 777 92 -27 re
f*
BT
0 0 0 1 scn
/TT0 1 Tf
0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2002; 29:1)Tj
0 Tw -46.2952 -0.0313 Td
(168)Tj
/TT1 1 Tf
0.02499 Tw 7.76 0 0 8 72 714.5293 Tm
[(linkage studies in families with )18 (T)70 (ype I diabetes mellitus. Diabetologia)]TJ
0 Tw 0 -1.25 TD
(2000;43:800-8.)Tj
-0.00011 Tc 0.02499 Tw -1.3943 -1.25 Td
[(7.)-644 (Huang QR, Morris D, Manolios N. Identification and characterisation)]TJ
0 Tc 1.3943 -1.25 Td
[(of polymorphisms in the promoter region of the human )55 (Apo-1/Fas)]TJ
T*
(\(CD95\) gene. Mol Immunol 1997;34:577-82.)Tj
-0.00011 Tc -1.3943 -1.25 Td
[(8.)-644 (Thiesen HJ, Koczan D, Ibrahim SM. )18 (The role of apoptosis in)]TJ
0 Tc 1.3943 -1.25 Td
(autoimmune disease with special reference to juvenile chronic)Tj
T*
(arthritis. Rev Rhum 1997;64:140-3.)Tj
-0.00011 Tc -1.3943 -1.25 Td
[(9.)-644 (Haas JP)111 (, Frank C, Haefner R, Herrmann M, Spaeth H, Ruder H.)]TJ
1.3943 -1.25 Td
(Inverted ratio of m-fas/s-fas expression in early onset pauciarticular)Tj
0 Tc T*
(juvenile chronic arthritis. Eur J Immunogenet 1999;26:325-9.)Tj
-0.00011 Tc -1.8943 -1.25 Td
[(10.)-644 (Sioud M, Mellbye O, Forre O. )55 (Analysis of the NF-)]TJ
/T1_0 1 Tf
0 Tc 0 Tw 22.3928 0 Td
(\002)Tj
/TT1 1 Tf
0.02499 Tw [0.2 (B p65 subunit,)]TJ
-20.4985 -1.25 Td
(Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of)Tj
T*
[(RA)-220 (and polyarticular JRA. Clin Exp Rheumatol 1998;16:125-34.)]TJ
32.1632 16.25 Td
[(1)37 (1.)-644 (Huang QR, )18 (T)70 (eutsch SM, Buhler MM, et al. Evaluation of the )55 (Apo-)]TJ
-0.00011 Tc 1.8575 -1.25 Td
(1/Fas promoter Mva I polymorphism in multiple sclerosis. Mult Scler)Tj
0 Tc 0 Tw T*
(2000;6:14-8.)Tj
0.0249 Tw -1.8943 -1.25 Td
[(12.)-644 (Huang QR, Danis )18 (V)129 (, Lassere M, Edmonds J, Manolios N. Evaluation)]TJ
-0.00011 Tc 1.8943 -1.25 Td
[(of a new )55 (Apo-1/Fas promoter polymorphism in rheumatoid arthritis)]TJ
0 Tc T*
(and systemic lupus erythematosus patients. Rheumatology)Tj
0 Tw T*
(1999;38:645-51.)Tj
0.0249 Tw -1.8943 -1.25 Td
[(13.)-644 (Gattorno M, Picco P)111 (, Buonocompagni )55 (A, et al. Serum p55 and p75)]TJ
-0.00011 Tc 1.8943 -1.25 Td
(tumour necrosis factor receptors as markers of disease activity in)Tj
0 Tc T*
[(juvenile chronic arthritis. )55 (Ann Rheum Dis 1996;55:243-7.)]TJ
ET
Q
Q
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 CS 0 0 0 1 SCN
/GS1 gs
54 54 m
558 54 l
S
Q
Q
q
1 0 0 1 -18 0 cm
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 cs 0 0 0 0 scn
120.25 59.75 407.5 -10.83 re
f*
Q
Q
q
1 0 0 1 -19 0 cm
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 CS 0 0 0 1 SCN
0.5 w
120.25 59.75 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
ET
/GS2 gs
BT
/T1_1 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_2 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
8 0 obj
<>
endobj
74 0 obj
<>
endobj
533 0 obj
<>
endobj
35 0 obj
<>
endobj
39 0 obj
<>
endobj
36 0 obj
<>
endobj
62 0 obj
<>stream
HtVPTe} nR *.jQ78
+q+$:(k#Vm5!&(fG46uU'Sm5_< zb-4My*"[H딪Hm;_f}Ϗ7:(ϻ=/ۀ̽P˸Vw{4;ZW;AHò'K]ŋ[XWB@OG$[=BeE40o>ozOjW!E5y (E*mCJ"nD=fIK63UȫpO# Y*`~x4a
F""
1H||K|QG^:l-o_TQ6uvgn`wF6B"Yz-F8ˢU~c>`q`\Sװ
&~'JSw[aA-mf598m
,g(@;R4nbfhíS}dzk>V%LQ/֊&qZk}tccIe 3݄-[xwCk]ӧ:ZkVވR$4`^Of36. C$`FHӚV}3z͚omX_z {1S1fu=twq"ubX!~-N+)eL癃eE:!Zeiy\mK{KQX=WUѣVo`6^ft&کv,18DzYQen]ܷC2;+FѢy~1Q213[TjN {XGCg9qtM$}%%!3OfBJͤ7el"DLv^]ѾS}~V_Hp:f:f9#K{]ϻq]]SrVo*qPeqn>#Hyn$d|IOKDʀI߫gq.CפЀQAS4&LV!!hzh*ym7ϣ>z{{)<1:{'`x̏]̙ZAoTz[<ٖ7rO^/7xaAO,Yn
cePU`Bd#`9kZF TmOz+b\ ،ۮy:gg]džFv*)L*MTgb&~3i]R`C( 45&tA6R+aX+;sﬢ(Kcb#Td1@/%`&+
ɫGyٔcM^?ߩN{N2&2MSeb0QSrlJ!wt(G-řpJT`"m'4:,?B:NGvE5?ꔉ9r4e7//Q/'o#ӞH\%
J"KYDDwѢb0JkFk.:OcbMKD9O<ϫJ
U{՞\H]j\˦ɑ r!uvb]9yYU݉;(3/e[9> ֓}rȘõX#@;ǴXT]]5UN9*&qPn#1Daf1
yuξ(Vp]@;;Jdfvmj\܊z̳FH_+ufNV0!yĞjm'Kn}Cy8Ζ<|>0bqXGD4~.5V斳SfT͉{gu9ݙ)7.u٫^Gg濜W}lS=w8y v!ώM " Mm RR(H&:(Qۡ Eick;15iI4h^BJcړ}{w9{ی 2=K+Ȇ|@w7s1W$yMsihaB-̼25ITɖ0Jm%Lw 3zS+QLp L-6n<% ;ZI\~Nf1ΰBooVv̓AW,
Y7p_q:xfr/*wB=ʫؓ +eP%Y)4^`M'g؍~1}<>W`BQ^z*jeev)]2)*%i8x&leÜbGa$VaWzr[9S?~@=EPՔrQTeLZM+iV2-mNa!B'*L2^GRa1&`jeޗcZtYSVXW*śIDZ,./X"'l_Zv{tDjQˊ,[`=ԩ"xDjBS"J
T*)8fQQfÈ8bX2%{Kctid"^ɤWM S̽58J^WY%G~?IisSp*m)|s\nAp:ߑz]klc%cu^ݙ:쌦v;t9i4KHL&C=6ľXll'61VLc=R,ql"]3\/n.Pߔ'`ǧPy7B$H˚H(QPMYţuuucuͺ:Ӎyz
;cyYbm\ᑯCAPYVTFUM}6Ϡ2PTQyeTP'=z5J
wX!<<4*vT$ì%ݐ}:eplэ PzC6Z,
_qD"s&PNN.¹&pUW!?2TW"ה۸2o<
/sM.skuUmD>XhŗzCZ#/]ZT'|9 lh#?L
:0Z>*G